Revium Rx CFO Arie Gordashnikov resigns; Igor Bluvstein appointed effective May 27, 2026

Revium Rx.

Arie Gordashnikov resigned as CFO effective May 27, 2026, with no disagreement with the company.
Igor Bluvstein appointed CFO same date; previously CFO at Argent BioPharma and G Medical Innovations.
Bluvstein receives monthly retainer of NIS17,000 plus VAT.
Bluvstein has over 17 years of financial leadership experience and is a CPA.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Igor Bluvstein

Chief Financial Officer

RVRC · Revium Rx.

Effective: 2026-05-27
Filed: June 1, 2026, 9:58 AM ET

On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.

Departed

Arie Gordashnikov

Chief Financial Officer

RVRC · Revium Rx.

Effective: 2026-05-27
Successor: Igor Bluvstein
Filed: June 1, 2026, 9:58 AM ET

On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Igor Bluvstein was appointed as Chief Financial Officer at Revium Rx..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Arie Gordashnikov resigned as Chief Financial Officer at Revium Rx..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.

View on SEC.gov

Revium Rx. filing history →

Source: SEC EDGAR

accession 0001213900-26-063235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.